President, Drug Product
Scott Wagner joined Curia in January 2019 in Operations and transitioned to President in 2023. His role as President is to lead sales and operations for four drug product sites (Glasgow, Camarillo, Burlington, Albuquerque) that provide clinical and commercial services for small and large molecule sterile injectable drug products.
Scott brings more than 25 years of experience in pharmaceutical manufacturing. Prior to Curia, Scott worked at Akorn Inc., for three years, serving as senior vice president, pharmaceutical operations. Scott worked for more than 22 years at Pfizer, Hospira and Abbott in various global and site roles in external manufacturing supply, program management, engineering and validation.
Scott earned a Bachelor of Science in mechanical engineering from Ohio University in Athens, Ohio.